|
MLST (ST)
|
SCCmec type
|
spa-type
|
Number of isolates
|
Nucleotide mutation
|
Amino acid substitution
|
Resistance pattern
|
|---|
|
ST239
|
III
|
t030
|
24
|
CAT/AAT+TTA/TCA
|
481His/Asn+466Leu/Ser
|
CIP+E+GEN+TET(1)
|
|
CIP+E+GEN+TET+CC(23)
|
|
1
|
CAT/AAT+GCT/GAT
|
481His/Asn+477Ala/Asp
|
CIP+E+GEN+TET+CC (1)
|
|
ST239
|
III
|
t021
|
2
|
CAT/AAT+TTA/TCA
|
481His/Asn+466Leu/Ser
|
CIP+E+GEN+TET+CC(2)
|
|
ST239
|
III
|
t045
|
1
|
CAT/AAT+TTA/TCA
|
481His/Asn+466Leu/Ser
|
CIP+E+GEN+TET+CC+SXT(1)
|
- CIP, ciprofloxacin; E, erythromycin; CC, clindamycin; TET, tetracycline; SXT, sulfamethoxazole/trimethoprim; GEN, gentamycin; QD, quinupristin/dalfopristin.
